Latest news with #AbhishekJha
The Hindu
04-08-2025
- Business
- The Hindu
Diageo India added ₹49,000 crore to Indian economy: report
Diageo India's operations added approximately ₹49,000 crore in value to the Indian economy in 2023-24 and the company supported nearly 6.5 lakh jobs in that year said Pahlé India Foundation (PIF), in its report 'Economic and Social Impact Assessment of Diageo India'. Employing the input-output model developed by Nobel Laureate Professor Wassily Leontief, the report which provides an in-depth analysis of the company's national footprint, has quantified the company's direct and indirect impact on employment. Out of the ₹49,000 crore in that specific year (FY 2024) the direct contribution of Diageo India was ₹25,300 crore and the remaining was indirect through the economic activities and demand generated by the company, said Abhishek Jha, the author of the report. The findings highlight how procurement-related activities are creating forward and backward linkages across various industries encompassing primary agriculture, transportation and logistics, packaging, hotels, trade, and tourism. In addition to traditional financial metrics, the report has covered factors such as employee satisfaction, sustainability initiatives, corporate social responsibility (CSR) activities, as well as fiscal contributions to government revenues. In sustainability front, the company in FY 2025 had cut water consumption by 11%, water withdrawal by 10%. This was achieved as a result of efforts made at the plant level. The company improved its water-use efficiency by 48% in distilleries and by 31% in packaging, as per the report. The company had also eliminated coal use, and reduced Scope 1 and Scope 2 emissions by 87% and 98% respectively. As a part of decarbonisation strategy, the company increased its in-house solar energy capacity to 2.6 MW and achieved 98.6% renewable energy use status in direct operations, according to the report. The company spends approximately ₹20 crore on CSR programs each financial year, impacting over 1,00,000 people across various regions. The programs are focused on community development, increasing agro-produce and agri-income, healthcare, water access, providing sanitation facilities, women's empowerment, and livelihood generation around the company's 36 manufacturing facilities across several states. Rajiv Kumar, Chairperson, PIF, said: 'The alcobev industry stands at the crossroads of agriculture, logistics, tourism, and retail. With targeted reforms to improve ease of doing business, especially in taxation and interstate trade, India can become a key player in the $5.7 trillion global spirits market by 2032.' 'We must recognise that India cannot become 'first' unless the private sector is empowered. Anchor investors, such as Diageo, are vital to this transition. If the company can deepen its cultural and social presence, it can contribute to redefining India's global manufacturing footprint,' he said. 'Simplifying licensing norms and harmonising excise policies across states will be critical to making 'Made in India' alcobev products globally competitive,' he added. Praveen Someshwar, Managing Director and Chief Executive Officer, Diageo India in a statement said, 'As India embarks on its transformative journey towards Viksit Bharat, Diageo India remains a committed partner in this endeavour, contributing to India's emergence as a global economic powerhouse by 2047.' 'Our alignment with the nation's priorities — driving investments, fostering innovation, creating jobs, advancing sustainability, and enabling inclusive progress — reflects our commitment to shaping a future that is both prosperous and inclusive,' he said. 'This Economic and Social Impact Assessment by Pahlé India Foundation highlights our strategic investments in people, partners, and national development,' he added.
Hindustan Times
03-07-2025
- Health
- Hindustan Times
3 major takeaways from nutritional intake data
... Next Story By Abhishek Jha , Roshan Kishore Jul 03, 2025 08:40 AM IST {{#userSubscribed}} {{/userSubscribed}} {{^userSubscribed}} {{/userSubscribed}} {{^userSubscribed}} {{/userSubscribed}} The National Sample Survey Office (NSSO) released its report on nutritional intake in India after more than a decade earlier this week. The latest report gives data for 2022-23 and 2023-24. To be sure, the nutritional intake surveys are essentially extrapolated numbers using quantities of food items consumed as seen in Household Consumption Expenditure Surveys (HCES). HT has already reported that the latest report largely shows an improvement in nutritional intake between 2011-12 and 2023-24. This key takeaway notwithstanding, there are some other interesting trends in the report. Here are three charts that summarise them. File picture {{^userSubscribed}} {{^usCountry}} {{/usCountry}} {{#usCountry}} {{/usCountry}} {{/userSubscribed}} {{^userSubscribed}} {{^usCountry}} {{/usCountry}} {{#usCountry}} {{/usCountry}} {{/userSubscribed}} SHARE THIS ARTICLE ON
Business Wire
04-06-2025
- Business
- Business Wire
Elucidata and Sapien Biosciences Announce Strategic Partnership to Transform Biobank Assets into high quality AI Products
SAN FRANCISCO & HYDERABAD, India--(BUSINESS WIRE)--Elucidata, a leader in data-centric AI for drug discovery and translational research, and Sapien Biosciences, India's first and largest commercial biobank with 300,000+ patient samples founded in partnership with Apollo Hospitals, today announced a strategic partnership to convert Sapien's extensive biobank assets into AI-ready, multimodal data products for use in drug and diagnostic development. Through this collaboration, Sapien will harness Elucidata's platform to integrate, standardize, and enrich its vast repository of biospecimens and curated clinical data, making them accessible for predictive modeling, synthetic data generation, and advanced genomics research. The partnership reflects a shared focus on turning real-world patient data into high-value actionable insights that drive precision medicine and improve outcomes worldwide. With access to over 300,000 patient samples across oncology, cardiology, autoimmune, inflammation, neurology, and other diseases, Sapien operates at a scale matched by few biobanks worldwide. This includes more than 85,000 cancer patients, increasingly paired with digitized histopathology images, genomic profiles, and structured longitudinal clinical data, making it one of the top 10 biobanks globally and the largest integrated resource for Asian patient data. 'At Sapien, we believe that deeply characterized patient data especially from underrepresented populations like those in India can catalyze more inclusive and effective diagnostics and therapies worldwide,' said Dr. Jugnu Jain, CEO and Co-founder of Sapien Biosciences. 'This partnership with Elucidata enables us to convert our rich biological and clinical datasets into interoperable, AI-ready formats, unlocking their potential for translational research, patient stratification, and precision drug development.' The first phase of the collaboration will focus on building AI models that infer genomic and transcriptomic insights from digital pathology images. By using NGS-annotated slides from Sapien's cancer biobank, the project will enable the generation of synthetic multi-modal datasets essential for next-generation diagnostic tools and tissue-sparing research strategies. This is particularly valuable for rare cancers and limited biopsy specimens. 'Sapien's scale, sample quality, and data depth make it a critical partner in our mission to democratize access to high quality, AI-ready biomedical data,' said Dr. Abhishek Jha, CEO and Co-founder of Elucidata. 'By applying our Polly platform to Sapien's datasets, we can bridge the gap between fragmented sample collections and next-gen AI models that accelerate target discovery and biomarker validation.' In addition to oncology, the partnership will explore multi-disease use cases across Sapien's biobank, including cardiovascular, autoimmune, and neurological disorders, building synthetic clinicogenomic datasets that support pharma R&D and companion diagnostic development. 'This partnership between Elucidata and Sapien Biosciences brings together Sapien's extensive, high-quality biobank resources and Elucidata's expertise in AI-powered data integration. By making rich biospecimens and clinical datasets AI-ready, this collaboration has the potential to accelerate global innovation and help reduce the complexity of human biology for research and patient care,' said Dr. Navjot Singh, advisor of and healthcare leader with 22 years of expertise in strategy, technology, and innovation, most recently as a Senior Partner at McKinsey & Company. Elucidata recently ranked 7th in the Broad Institute's Autoimmune Disease Machine Learning Challenge and recently won the National Cancer Institute's Cancer Research Data Commons AI Data Readiness Challenge, highlighting its leadership in data-centric AI for life sciences. About Elucidata Elucidata is a data-first AI company that accelerates life sciences R&D by converting fragmented biomedical datasets into harmonized, AI-ready assets. Its proprietary Polly platform integrates EHRs, genomics, imaging, and clinical trial data for seamless downstream analysis and model development. Headquartered in San Francisco with offices across the U.S. and India, Elucidata supports over 70 pharma and diagnostics clients, and has contributed to 16 drug programs progressing toward FDA approvals. Recognized by the National Cancer Institute and Fast Company for its innovation in biotech, Elucidata is enabling a new era of data-driven discovery. Visit for more information. About Sapien Biosciences Founded in partnership with Apollo Hospitals, Sapien Biosciences is India's premier multi-disease biobank and a leader in Indian real-world evidence (RWE) for personalized medicine. With access to more than 300,000 patients' samples including 2 million pathology samples, Sapien offers FFPE tissues, blood, and liquid biopsy samples along with annotated histopathology slides and longitudinal clinical data. Its resources support a broad range of applications from AI/ML modeling and multi-omics research to drug screening in patient tumor-derived cells and biomarker discovery. Sapien has published over 10 peer-reviewed studies using Indian patient data and collaborates with leading diagnostic and pharma companies to reduce the representation gap in global omics datasets. Learn more at
Time of India
16-05-2025
- Time of India
2 more of 6 accused in gang rape arrested after police encounter in Bijnor
Bijnor: A day after three of six accused in the alleged gang rape of a 21-year-old Dalit woman were arrested, two more were taken into custody, while a third, a minor, was detained on Friday following an encounter with police. Bijnor SP Abhishek Jha, said, "Acting on a tip-off, police intercepted the remaining three accused near Chidiapur. During the encounter, one of the accused sustained a bullet injury to his leg and was taken to the district hospital for treatment. One of the accused is a minor and has been detained for interrogation." The woman was allegedly gang-raped by six men in front of her fiance in a field near her village in Bijnor district on May 10. The accused, from the same village, assaulted her fiancé, restrained him, before taking turns to violate her. They also filmed the act. Fearing for her safety, the woman initially remained quiet and only spoke about her ordeal when the accused circulated the video on social media. The SP said that a case was registered against the six accused under sections 70(1), 351(2), 115(2) of BNS, sections 3(2)(5) of SC/ST Act , and 67(a) of IT Act.
Hans India
15-05-2025
- Business
- Hans India
Young Entrepreneurs Launch Quanttrix – India's Smartest Artificial Intelligence Trading Bot
Since the scenario of trading in India is dynamically changing at present, there is a new generation of traders emerging in the market. Trendy Traders, a group of new generation financial technological enthusiasts, has brought a cutting-edge algo trading company in India that is revolutionising stock market trading. with the launch of There is nothing else like for applying AI for trading stocks and full automation technique for the traders. Thanks to the use of complex algorithmic trading strategies and artificial intelligence, the trading system is free from an opinion, efficient in terms of transactions and productive in terms of revenues. Thirdly, has an artificial intelligence trading bot for efficiency in high-frequency trade, thus suitable in trading for both common individual to traders with large capital. Meet the Founders Behind Mr. Niraj Mittal – Co-Founder and CEO Niraj Mittal is an experienced investor and trader in the financial markets having over 10 years of experience in this profession and also has a speciality in market analysis coupled with algorithmic strategies. Certified as a Research Analyst from NISMSE, he is analytically inclined and believes in the strength derived from data analysis. Mr. had provided great leadership and foresight to and the company has been able to come up with unique algo trading and automated investment solutions. Mr. Abhishek Jha – Co-Founder and COO {H2} Abhishek Jha is a gifted trader with having tenure of more than 8 years in stock exchange market. The author of this article being an NISM SEBI Investor Exam certified stock market professional, he is ranked among the best stock trading tutors in India. His vast knowledge from technical analysis to strategies involving the use of algorithms is invaluable for traders to use when dealing with the market. As it relates to Constantine aims to help retail traders by automating and making trading tasks easier. A Game-Changer in Artificial Intelligence Trading Bot {H2} is changing the face of algorithmic trading strategies with the means of live AI market analysis coupled with built-in trading execution. As opposed to tried and tested conventional approaches that bring decision-making to a halt due to market fluctuations and human mistakes, trading with involves the utilization of an AI-driven approach that is based on the extraction of data and analysis of the likelihood of market movements. Key Features of {H3} AI-Powered Market Insights – Uses AI for trading stocks to analyze market data and detect profitable opportunities. Automated Trading Execution – Enables precise, real-time trades with the artificial intelligence trading bot. Advanced Risk Management – Includes stop-loss mechanisms, portfolio balancing, and strategy optimisation. Customizable Algorithmic Strategies – Traders can modify pre-built algorithmic trading strategies or create personalised automation rules. Cloud-Based Scalability – Designed to support high-frequency trading for both individuals and financial institutions. Why is a Leading Algo Trading Company in India {H2} The founders of Trendy Traders envisioned a platform that simplifies algorithmic trading while maximising efficiency. Here's why is gaining popularity among traders: Efficiency – AI-powered bots execute trades instantly, ensuring traders never miss market opportunities. Profitability – AI-driven strategies increase the chances of higher returns with data-backed insights. Accessibility – Unlike conventional systems requiring technical expertise, provides algorithmic trading strategies for traders with no coding knowledge. Transparency – The AI engine processes market data in real time, ensuring traders have full visibility over their automated trading activities. Whether users need institutional-grade trading automation or simplified AI-driven assistance, caters to all levels of expertise, making it a game-changer in India's financial market. How is Changing Trading in India {H3} IT has been a very important ingredient in the Indian markets due to its increasing accent on the use of automation. is crucial as it offers the services of using AI for trading stocks and achieving perfect accuracy and speed. Retail Traders – Improve trading strategies using AI-generated insights. Professional Investors – Implement complex algorithmic trading strategies with speed and precision. Institutions & Hedge Funds – Utilise artificial intelligence trading bot systems for large-volume trades. By democratising AI-powered trading, ensures that both beginner traders and experienced professionals can access institutional-level tools without complex infrastructure requirements. Conclusion The founders of Trendy Traders are going straight to the heart of a new model within the trading platform of India with the algo trading company in India, The use of artificial intelligence in the development of algorithmic trading strategies improves the ability of a trader, efficiency, precision, and overall effectiveness of trades. With AI for trading stocks and artificial intelligence trading bot technology, represents the future of financial automation. Want to take advantage of AI-powered trading? Explore today and experience the next generation of algorithmic trading in India! FAQ'S 1. What is is an AI-powered algorithmic trading platform developed by the team behind Trendy Traders, a prominent stock market education brand in India. It enables traders to automate their strategies with precision, offering seamless, high-speed, and intelligent trading solutions. 2. Is Quanttrix an algo trading company in India? Yes, Quanttrix is a cutting-edge algo trading company based in India, dedicated to transforming how traders and investors navigate the stock market. 3. How does Quanttrix use artificial intelligence for trading stocks? Quanttrix utilizes AI-driven algorithms to optimize trade execution, analyze market trends, and adjust strategies in real-time, enhancing precision and profitability. 4. What algorithmic trading strategies does Quanttrix support? Quanttrix offers a variety of AI-driven algorithmic trading strategies, including: Momentum Shield: A non-directional intraday strategy adapting to market volatility for consistent performance. StrikeShift SenSex: A delta-neutral options strategy that recalibrates strike selection for optimal delta positioning. 5. Can beginners use Quanttrix? Absolutely. Quanttrix is designed to simplify trading for individuals of all levels, including beginners. Its user-friendly interface and AI-powered automation make it accessible for those new to trading. 6. What markets does Quanttrix currently support? Quanttrix supports trading in Indian equity, index, and derivatives markets, integrating seamlessly with leading brokers like Dhan. 7. What is an artificial intelligence trading bot, and how does Quanttrix use it? An AI trading bot is software that uses machine learning to make and execute trading decisions automatically. Quanttrix's AI-powered bots analyze market movements, automate trade execution, and provide real-time insights. 8. Is it safe to use AI bots for trading? Yes, Quanttrix emphasizes smart risk management, including features like stop-loss, position sizing, and hedging strategies to minimize drawdowns while maximizing profitability. 9. How is Quanttrix different from other algo trading platforms in India? Quanttrix stands out due to its AI-powered trading automation, ultra-fast execution, backtesting capabilities, real-time monitoring, and a no-code platform, making it accessible and efficient for traders. 10. Is Quanttrix SEBI-complaint? Yes, Quanttrix operates within SEBI regulations, providing a legal and compliant solution for algo trading in India, ensuring traders can use automated strategies safely and effectively.
